We have joined with Evolution Biologyx, which has the exclusive rights to market, sell, promote and sell into the office space a true and permanent FDA-designated 361 product called Interfyl. Interfyl is a minimally manipulated extracellular matrix developed from the chorionic plate/disc of the placenta and can be used in a homologous fashion in loose and dense connective tissue applications. Interfyl can be administered in an office via an injectable application. We are trying to work within the new 361/351 guidelines and offer both patients and health care providers what we feel is both a viable and legal option. Please call us to learn more. 603-533-4323.